1. Home
  2. RVYL vs EVOK Comparison

RVYL vs EVOK Comparison

Compare RVYL & EVOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RVYL
  • EVOK
  • Stock Information
  • Founded
  • RVYL 2007
  • EVOK 2007
  • Country
  • RVYL United States
  • EVOK United States
  • Employees
  • RVYL N/A
  • EVOK N/A
  • Industry
  • RVYL Professional Services
  • EVOK Biotechnology: Pharmaceutical Preparations
  • Sector
  • RVYL Consumer Discretionary
  • EVOK Health Care
  • Exchange
  • RVYL Nasdaq
  • EVOK Nasdaq
  • Market Cap
  • RVYL 7.3M
  • EVOK 7.6M
  • IPO Year
  • RVYL N/A
  • EVOK 2013
  • Fundamental
  • Price
  • RVYL $0.31
  • EVOK $10.70
  • Analyst Decision
  • RVYL Hold
  • EVOK
  • Analyst Count
  • RVYL 1
  • EVOK 0
  • Target Price
  • RVYL N/A
  • EVOK N/A
  • AVG Volume (30 Days)
  • RVYL 9.6M
  • EVOK 235.3K
  • Earning Date
  • RVYL 11-13-2025
  • EVOK 11-07-2025
  • Dividend Yield
  • RVYL N/A
  • EVOK N/A
  • EPS Growth
  • RVYL N/A
  • EVOK N/A
  • EPS
  • RVYL N/A
  • EVOK N/A
  • Revenue
  • RVYL $48,904,000.00
  • EVOK $12,794,859.00
  • Revenue This Year
  • RVYL N/A
  • EVOK $57.38
  • Revenue Next Year
  • RVYL $297.49
  • EVOK $59.57
  • P/E Ratio
  • RVYL N/A
  • EVOK N/A
  • Revenue Growth
  • RVYL N/A
  • EVOK 70.02
  • 52 Week Low
  • RVYL $0.25
  • EVOK $1.94
  • 52 Week High
  • RVYL $2.33
  • EVOK $10.79
  • Technical
  • Relative Strength Index (RSI)
  • RVYL 50.97
  • EVOK 84.11
  • Support Level
  • RVYL $0.28
  • EVOK $4.50
  • Resistance Level
  • RVYL $0.30
  • EVOK $10.73
  • Average True Range (ATR)
  • RVYL 0.06
  • EVOK 0.25
  • MACD
  • RVYL -0.00
  • EVOK 0.55
  • Stochastic Oscillator
  • RVYL 21.29
  • EVOK 98.25

About RVYL Ryvyl Inc.

Ryvyl Inc is a technology company that develops, markets and sells blockchain-based payment solutions, which offers improvements to the payment solutions marketplace. Its focus is developing and monetizing disruptive blockchain-based applications, integrated within an end-to-end suite of financial products, capable of supporting a multitude of industries. Its proprietary, blockchain-based systems are designed to facilitate, record, and store a limitless volume of tokenized assets, representing cash or data, on a secured immutable blockchain-based ledger. It has two reportable segments North America and International. It generates the majority of its revenue from North America.

About EVOK Evoke Pharma Inc.

Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.

Share on Social Networks: